Digital Genomes
A Global Strategic Business Report
MCP33720
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETINGHIGHLIGHTS & REPORT INDEX
Global Digital Genomes Market to Reach US$72.8 Billion by 2030
The global market for Digital Genomes estimated at US$33.7 Billion in the year 2024, is expected to reach US$72.8 Billion by 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Sequencing & Analyzer Instruments, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$31.8 Billion by the end of the analysis period. Growth in the DNA / RNA Analysis Kits segment is estimated at 11.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$8.9 Billion While China is Forecast to Grow at 12.8% CAGR
The Digital Genomes market in the U.S. is estimated at US$8.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.
Global Digital Genomes Market – Key Trends & Drivers Summarized
Is Precision Health Entering the Age of the Digital Genome?
Digital genomes—virtual representations of an individual’s complete genetic code stored and analyzed using advanced computing systems—are transforming the landscape of personalized medicine, drug development, and disease prevention. The global market for digital genomes is being driven by the convergence of next-generation sequencing (NGS), AI-enabled bioinformatics, and cloud-based data storage, enabling rapid, scalable, and cost-effective genetic analysis.
A defining trend is the shift from siloed genetic testing to integrated digital genome platforms, which consolidate raw DNA data, phenotype linkage, health records, and real-time monitoring into unified interfaces. These platforms are finding increasing use in oncology, rare disease diagnostics, pharmacogenomics, and population genomics initiatives. Countries such as the U.S., U.K., and China are investing in national-scale genome mapping projects, boosting the adoption of data-rich, cloud-secure digital genome infrastructure.
How Are Technological Convergences Unlocking Genomic Potential?
AI and machine learning algorithms are central to the digital genome revolution, facilitating rapid variant detection, risk modeling, and therapeutic target identification. These technologies are helping clinicians interpret complex genomic datasets and match them with optimal treatments—ushering in an era of predictive and preventive medicine. Moreover, real-time updates to individual genome profiles via wearable-integrated health data are becoming possible, especially in longitudinal health studies.
Advancements in storage and encryption technologies are also making secure sharing of genetic data feasible. Federated data models and blockchain are being explored to allow decentralized access to genomic data without compromising patient privacy, a key concern in regulated environments like the EU under GDPR or the U.S. under HIPAA.
Where Is Demand Accelerating and Who Are the End-Users?
The digital genome market is expanding rapidly in North America and Europe, with Asia-Pacific emerging as a strategic growth frontier due to government-backed genome sequencing programs and expanding biotech ecosystems. End-users include academic research institutions, hospitals, biopharmaceutical companies, direct-to-consumer (DTC) genetic testing providers, and health insurers.
Population health initiatives—such as the UK`s 100,000 Genomes Project or the NIH`s All of Us research program—are key growth catalysts, while private genetic testing companies are deploying consumer-facing genome dashboards to connect genetic risk with lifestyle and wellness interventions.
What’s Driving Growth in the Digital Genomes Market?
The growth in the digital genomes market is driven by a confluence of genomic science, AI analytics, and demand for precision medicine. Rising affordability of whole genome sequencing, along with increased accessibility to cloud computing, is enabling more institutions to adopt digital genome platforms.
Healthcare systems are recognizing the value of genomics in risk stratification and early intervention, particularly in oncology, cardiology, and neurology. Pharmaceutical firms are using digital genome datasets to identify novel drug targets and stratify trial participants based on genetic responsiveness. Regulatory clarity and global collaborations on data sharing are further fueling the integration of digital genomes into mainstream medicine.
SCOPE OF STUDY
The report analyzes the Digital Genomes market by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Preparation Instruments); Application (Clinical, Forensics, Drug Discovery & Development, Other Applications); End-User (Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes, Other End-Users).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..
SELECT PLAYERS
10x Genomics; Agilent Technologies, Inc.; ArcherDx, Inc.; BGI Genomics; bioMérieux SA; Bio-Rad Laboratories, Inc.; Eurofins Scientific SE; Fabric Genomics, Inc.; Foundation Medicine, Inc.; Genewiz; Guardant Health, Inc.; Illumina, Inc.; Invitae Corporation; Myriad Genetics, Inc.; NanoString Technologies, Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California, Inc.; PerkinElmer, Inc.; QIAGEN N.V.; Thermo Fisher Scientific Inc.
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| World Market Trajectories |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Digital Genomes – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 44 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Advances in Genomic Sequencing Technologies Propel Demand for Digital Genome Platforms |
| Rising Use of AI in Genomic Data Interpretation Accelerates Clinical Application of Digital Genomes |
| Personalized Medicine Trends Strengthen Business Case for Genome Digitization |
| Integration of Genomic Data with EHR Systems Enhances Predictive Healthcare Models |
| Growing Demand for Population-Wide Genomic Screening Expands Digital Genome Infrastructure Investment |
| Increased Focus on Rare Disease Diagnosis Drives Adoption of Comprehensive Genomic Databases |
| Data Privacy Regulations in Genomics Create Both Challenges and Opportunities for Secure Platform Development |
| Collaborations Between Biotech Firms and Cloud Providers Spur Innovation in Scalable Genome Data Storage |
| Pharma R&D Shifts Toward Genotype-Driven Drug Discovery Highlights Need for Digital Genome Platforms |
| Public Health Genomics Programs in Asia and Europe Generate Long-Term Growth Opportunities |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Digital Genomes Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Sequencing & Analyzer Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Sequencing & Analyzer Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for DNA / RNA Analysis Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for DNA / RNA Analysis Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Sequencing Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Sequencing Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Sequencing & Analysis Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Sequencing & Analysis Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Sample Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Sample Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Diagnostic Centers & Forensic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Diagnostic Centers & Forensic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| JAPAN |
| Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| CHINA |
| Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| EUROPE |
| Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| FRANCE |
| Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| GERMANY |
| Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| UNITED KINGDOM |
| Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| ASIA-PACIFIC |
| Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]